2016
DOI: 10.1016/j.jacc.2016.07.718
|View full text |Cite
|
Sign up to set email alerts
|

Redefining Reverse Remodeling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(10 citation statements)
references
References 24 publications
0
10
0
Order By: Relevance
“…An increasing body of evidences in other pathological contexts, point to the fact that reverse remodeling starts at end-systole due to improvement of contractile function of the heart following the abolishment of either volume or pressure load. 28 To our knowledge this is the first paper to determine the status of MVP following transcatheter ASD closure and to correlate it to Biventricular reverse remodeling. In our patients, significant agreement has been depicted between results of biventricular remodeling as measured by 3D RV: LV ratio and MVP status.…”
Section: Discussionmentioning
confidence: 99%
“…An increasing body of evidences in other pathological contexts, point to the fact that reverse remodeling starts at end-systole due to improvement of contractile function of the heart following the abolishment of either volume or pressure load. 28 To our knowledge this is the first paper to determine the status of MVP following transcatheter ASD closure and to correlate it to Biventricular reverse remodeling. In our patients, significant agreement has been depicted between results of biventricular remodeling as measured by 3D RV: LV ratio and MVP status.…”
Section: Discussionmentioning
confidence: 99%
“…Adverse LV remodelling can be defined as an increase in LVESV >15% at follow‐up compared with baseline values 16 . A cutoff of >15% decrease from the baseline in LVESV was considered as a criterion of reverse LV remodelling, as this value is a validated reverse remodelling index in patients with ischemic heart disease 17,18 …”
Section: Methodsmentioning
confidence: 99%
“…Activation of inflammatory and coagulant pathways, cardiac fibrosis and microvascular obstruction promote adverse LV remodeling [2,3]. Conversely, reduction in LV volumes, defined as "reverse" LV remodeling, occurs in a proportion of post-infarct cases and is associated with improved cardiac function which, alongside pharmacotherapy targeting neurohormonal pathways, results in improved outcome and reduced progression to HF [4,5]. Change in LV end systolic volume (LVESV; applying a cutoff of ±15%) at six months after MI is a widely accepted echocardiographic measure to define adverse (−) or reverse (+) LV remodeling [5,6].…”
Section: Introductionmentioning
confidence: 99%
“…Conversely, reduction in LV volumes, defined as "reverse" LV remodeling, occurs in a proportion of post-infarct cases and is associated with improved cardiac function which, alongside pharmacotherapy targeting neurohormonal pathways, results in improved outcome and reduced progression to HF [4,5]. Change in LV end systolic volume (LVESV; applying a cutoff of ±15%) at six months after MI is a widely accepted echocardiographic measure to define adverse (−) or reverse (+) LV remodeling [5,6]. Given the relatively high interobserver variability in echocardiographic measurement of cardiac volumes, combining changes in LVESV with circulating biological markers associated with the pathophysiological process of LV remodeling may improve the accuracy of risk stratification to better guide clinical management and ensure patients at high-risk of adverse LV remodeling receive more timely and effective intervention.…”
Section: Introductionmentioning
confidence: 99%